|86.49||+1.34 / +1.57%|
Data as of 4:00pm ET
|86.49||0.00 / 0.00%|
The 13 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 86.00, with a high estimate of 108.00 and a low estimate of 68.00. The median estimate represents a -0.57% decrease from the last price of 86.49.
The current consensus among 16 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.